5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach

S Sinha, M Doble, SL Manju - Bioorganic & Medicinal Chemistry, 2019 - Elsevier
The most common inflammatory disease of the airways is asthma among children affecting
around 235 million people worldwide. 5-Lipoxygenase (5-LOX) is a crucial enzyme which …

Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma

F Bruno, G Spaziano, A Liparulo, F Roviezzo… - European journal of …, 2018 - Elsevier
The products of 5-lipoxygenase are synthesized and released in the airway when an
asthmatic reaction occurs. 5-lipoxygenase via arachidonic acid metabolism produces …

The emerging therapeutic potential of nitro fatty acids and other Michael acceptor-containing drugs for the treatment of inflammation and cancer

M Piesche, J Roos, B Kühn, J Fettel… - Frontiers in …, 2020 - frontiersin.org
Nitro fatty acids (NFAs) are endogenously generated lipid mediators deriving from reactions
of unsaturated electrophilic fatty acids with reactive nitrogen species. Furthermore …

MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study

D Mirra, R Esposito, G Spaziano, L Sportiello, F Panico… - Biomedicines, 2024 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that is
commonly considered to be a potent driver of non-small cell lung cancer (NSCLC) …

An overview of lipoxygenase inhibitors with approach of in vivo studies

A Orafaie, M Mousavian, H Orafai… - Prostaglandins & Other …, 2020 - Elsevier
Lipoxygenases (LOXs) are enzymes which found in organisms that catalyze the
peroxidation of polyunsaturated fatty acids (Arachidonic acid, Linoleic acid). The key role of …

Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

U Garscha, E Romp, S Pace, A Rossi, V Temml… - Scientific reports, 2017 - nature.com
Arachidonic acid (AA) is metabolized to diverse bioactive lipid mediators. Whereas the 5-
lipoxygenase-activating protein (FLAP) facilitates AA conversion by 5-lipoxygenase (5-LOX) …

Finding new molecular targets of familiar natural products using in silico target prediction

F Mayr, G Möller, U Garscha, J Fischer… - International journal of …, 2020 - mdpi.com
Natural products comprise a rich reservoir for innovative drug leads and are a constant
source of bioactive compounds. To find pharmacological targets for new or already known …

Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents

O Werz, J Gerstmeier, U Garscha - Expert opinion on therapeutic …, 2017 - Taylor & Francis
ABSTRACT Introduction: Leukotrienes (LTs) are lipid mediators produced from arachidonic
acid with a broad variety of bioactivities in allergy and inflammation. The biosynthesis of LTs …

Beneficial Modulation of Lipid Mediator Biosynthesis in Innate Immune Cells by Antirheumatic Tripterygium wilfordii Glycosides

K Zhang, S Pace, PM Jordan, LK Peltner, A Weber… - Biomolecules, 2021 - mdpi.com
Tripterygium wilfordii glycosides (TWG) is a traditional Chinese medicine with effectiveness
against rheumatoid arthritis (RA), supported by numerous clinical trials. Lipid mediators (LM) …

In silico investigations of some Cyperus rotundus compounds as potential anti-inflammatory inhibitors of 5-LO and LTA4H enzymes

F Fenanir, A Semmeq, Y Benguerba… - Journal of …, 2022 - Taylor & Francis
The present study aimed to experimentally identify the essential oil of Algerian Cyperus
rotundus L. and to model the interaction of some known anti-inflammatory molecules with …